1Flens MJ, Zamon GJR, Van Der Valk P. Tissue distribution of the multidrug resistance protein [J].Am J Pathol, 1996;148(4):1237-1247.
2Nooter K, Herweijer H. Multidrug resistance(mdrl)genes in human cancer[J]. Br J Cancer, 1991 ;63(5):663-669.
3Chin JE, Soffir R, Noonan KE, et al. Structure and expression of the human MDR (P- glycoprotein) gene family[J]. Mol Cell Biol, 1989;9(9):3808-3820.
4Ueda K, Cardarelli C, Gottesman MM, et al.Expression of a full- length cDNA for the human "MDR1" gene confers resistance to colchicine,doxorubicin, and vinblastine[J]. Proc Natl Acad Sci USA, 1987;84(9): 3004-3008.
5Awqati QA. Regulation of ion channels by ABC transporters that secrete ATP[J]. Science, 1995;269(5225): 805-806.
7Schneider E, Cowan KH, Bader H, et al. Increased expression of the multidrug resistance- associated protein gene in relapsed acute leukemia[J]. Blood,1995;85(1) :186-193.
8Slovak ML, Ho JP, Cole SP, et al. The LRP gene encoding a major vault protein associated with drug resistance maps proximal to MRP on chromosome 16:evidence that chromosome breakage plays a key role in MRP or LRP gene amplification [J]. Cancer Res,1995;55(19) :4214-4219.
9Izquierdo MA, Scheffer GL, Flens MJ, et al. Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumors[J]. Am J Pathol, 1996;148(3):877-887.
10Doyle LA, Yang W, Abruzzo LV, et al. A multidrug resistance transporter from human MCF7 breast cancer cells[J]. Proc Natl Acad Sci USA,1998 ;95(26): 15665-15670.
5[2]Liu J, Qi S, Zhu H, et al. The effect of calmodulin antagonist berbamine derivative -EBB on hepatoma in vitro and vivo. Chin Med J, 2002;115:759-762
6[4]Marks DC, Belov L, Davey MW, et al. The MTT cell viability assay for cytotoxicity testing in multidrug-resistance human leukemic cells. Leuk Res, 1992;16:1165-1173
7[5]Michieli M, Damiani D, Ermacora A, et al. P-glycoprotein, lung resistance-related protein and multidrug resistance associated protein in de novo acute non-lymphocytic leukemias: biological and clinical implications. Br J Haematol, 1999:104:328-335
8[6]Lopes EC, Scolnik M, Alvarez E, et al. Modulator activity of PSC 833 and cyclosporin-A in vincristine and doxorubicin-selected multidrug resistant murine leukemic cells. Leuk Res, 2001 ;25:85-93
9[7]Moriai R, Asanuma K, Kobayashi D, et al. Quantitative analysis of the anti-apoptotic gene survivin expression in malignant haematopoietic cells. Anticancer Res, 2001 ;21:596-600
10[8]Massart C, Gibassier J, Lucas C, et al. Expression of the MDR1 gene in five human cell lines of medullary thyroid cancer and reversion of the resistance to doxorubicine by cyclosporin A and verapamil. Bull Cancer, 1996;83:39-45
6Scheper R J, Broxterman H J, Scheffer GL, et al. Overexpression of a M (r) 110000 vesicular protein in non-p-glycoprotein-mediated multidrug resistance [ J ]. Cancer Res, 1993, 53(7) : 1475-1479.
7Izquierdo MA. Shoemaker RH, Flens M J, et al. Overlapping phenotypes of multidrug resistance among panels human cancer cell lines [J]. Int J Cancer, 1996, 65(2) :230-237.
8Borst P, Evers R, Kool M, et al. A family of drug transporters : the multidrug resistance-associated proteins [ J ]. J Natl Cancer Inst ,2000,92 (6) : 1295-1302.
9Doyle LA, Ross DD. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2) [ J]. Oncogene ,2003,22:7340-7358.
10Rocchi E, Khodjakov A, Volk EL, et al. The product of the ABC half-transporter gene ABCG2 (BCRP/ABCP) is expressed in the plasma membrane [ J ]. Biochem Biophys Comm, 2000,271 ( 1 ) :42-46.
